Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
45,782,552
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
4,384,650
-
Shares change
-
+2,885,316
-
Total reported value, excl. options
-
$20,517,844
-
Value change
-
+$13,558,859
-
Put/Call ratio
-
2.01%
-
Number of buys
-
15
-
Number of sells
-
-11
-
Price
-
$4.68
Significant Holders of CAPRICOR THERAPEUTICS, INC. - Common Stock (CAPR) as of Q1 2021
39 filings reported holding CAPR - CAPRICOR THERAPEUTICS, INC. - Common Stock as of Q1 2021.
CAPRICOR THERAPEUTICS, INC. - Common Stock (CAPR) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,384,650 shares
of 45,782,552 outstanding shares and own 9.58% of the company stock.
Largest 10 shareholders include ORACLE INVESTMENT MANAGEMENT INC (1,999,464 shares), VANGUARD GROUP INC (912,033 shares), BlackRock Inc. (347,103 shares), Trellus Management Company, LLC (270,000 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (208,226 shares), GEODE CAPITAL MANAGEMENT, LLC (171,415 shares), NORTHERN TRUST CORP (96,941 shares), Bank of New York Mellon Corp (86,766 shares), CITADEL ADVISORS LLC (46,298 shares), and GROUP ONE TRADING, L.P. (41,089 shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.